Gray Hair Syndromes (GHSs), including Griscelli, Chediak-Higashi, Elejalde, and Cross syndromes, are rare autosomal recessive conditions characterized by silvery gray hair and severe multisystem impairments
Description 5-Amino-1MQ is positioned in research contexts as an NNMT (nicotinamide N-methyltransferase) pathway small molecule, not an NMN (nicotinamide mononucleotide) profile, with interpretation generally anchored to broader NNMT inhibition literature
Eli Lilly reported dysesthesia was "generally mild" and "rarely led to discontinuation." TRIUMPH-1 the larger general obesity trial with 2,339 patients at 80 weeks confirmed dysesthesia also occurs outside the osteoarthritis population, though at a lower rate than in TRIUMPH-4
The format is flexible, but the protein anchor is non-negotiable
The meta-analysis data shows mean reductions of 23.51 mg/dL in fasting plasma glucose and 0.91 percent in HbA1c